Screening novel products with bioactivities, such as antibodies, receptors and vaccines has become a convenient way to develop novel biopharmaceuticals.
用表面呈现技术构建文库并从中筛选新的生物活性物质，如抗体、 受体或疫苗，已成为研究生物新药的捷径之一。
A similar response is expected by changing the concentration of the DNA tethers, which could also be replaced by other types of ligand-receptor pairs, such as antibodies.
当改变DNA链的浓度时，也会有相似的响应，(DNA链)也可以用其他类型的配体-受体对替换，例如抗体。
The problem is that the molecules antibodies recognise and react to are the big ones, such as proteins, that are characteristic of bacteria, viruses and other infectious agents.
改为——问题是抗体能识别和做出反应的分子是像蛋白质这样的大分子，这也是细菌，病毒和其他致病原的特征。
应用推荐